About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Solasia Pharma K.K.(4597) Summary

4597
TSE Growth
Solasia Pharma K.K.
40
JPY
-1
(-2.44%)
Dec 23, 10:37 am JST
0.26
USD
Dec 22, 8:38 pm EST
Result
PTS
outside of trading hours
40.4
Dec 23, 10:38 am JST
Summary Chart Historical News Financial Result
PER
PBR
3.94
Yield
ー%
Margin Trading Ratio
2.75
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
41 JPY 0.26 USD
Previous Close Dec 20
41 JPY 0.26 USD
High Dec 23, 9:00 am
42 JPY 0.26 USD
Low Dec 23, 9:26 am
40 JPY 0.25 USD
Volume
5,010,800
Trading Value
0.21B JPY 1.31M USD
VWAP
40.9 JPY 0.26 USD
Minimum Trading Value
4,000 JPY 26 USD
Market Cap
8.73B JPY 0.06B USD
Number of Trades
146
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
Slightly High
1-Year Average
699
1-Year High Jul 25, 2024
6,835
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 8,100,900 29,930,700 3.69
Dec 6, 2024 8,375,000 29,418,500 3.51
Nov 29, 2024 11,489,000 30,941,500 2.69
Nov 22, 2024 9,927,800 27,345,200 2.75
Nov 15, 2024 8,012,400 27,672,100 3.45
Company Profile
Solasia Pharma K.K. is a biopharmaceutical venture company focused on cancer and malignant tumor drug discovery. The company engages in the development of pharmaceuticals and medical devices, with a primary focus on clinical development.
Sector
Pharmaceuticals